CLGN - CollPlant Biotechnologies Ltd.
NasdaqGM - NasdaqGM Real-time price. Currency in USD
At close: 03:53PM EDT
Stock chart is not supported by your current browser
| Previous close | 7.48 |
| Open | 7.44 |
| Bid | 7.44 x 1000 |
| Ask | 8.49 x 900 |
| Day's range | 7.26 - 7.60 |
| 52-week range | 4.27 - 13.97 |
| Volume | |
| Avg. volume | 7,555 |
| Market cap | 84.704M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs
EDEN PRAIRIE, Minn. & REHOVOT, Israel, April 04, 2023--Stratasys Ltd. (Nasdaq: SSYS) and CollPlant Biotechnologies (Nasdaq: CLGN) today announced a joint development and commercialization agreement to collaborate on the development of a solution to bio-fabricate human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks. The first project focuses on the development of an industrial-scale solution for CollPlant's regenerative breast implants
